Search Within

Irene Y Cheung

  1. "GSK Faculty"
Formats
  1. Journal Article (69)
  2. Meeting Abstract (24)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (93)
  2. GSK Faculty (93)
  3. General Oncology Service (93)
  4. Pediatrics, Department of (93)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (92)
  6. Neuroblastoma Service (92)

More Groups

People
  1. Nai-Kong Cheung (92)
  2. Brian Kushner (34)
  3. Shakeel Modak (28)
  4. Kim Kramer (16)
  5. Yi Feng (15)
  6. Stephen Roberts (14)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Clinical Cancer Research (12)
  3. Cancer Research (11)
  4. OncoImmunology (6)
  5. Pediatric Blood and Cancer (6)
  6. International Journal of Cancer (4)

More Publications

Publishers
  1. American Association for Cancer Research (27)
  2. American Society of Clinical Oncology (16)
  3. Wiley Periodicals, Inc (8)
  4. Landes Bioscience (6)
  5. John Wiley & Sons (4)
  6. Wiley Liss (4)

More Publishers

Results (93)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Dose escalation and curative therapy of colorectal cancer with anti-GPA33 self-assembling and disassembling (SADA) actinium-225 alpha pretargeted radioimmunotherapy
    Meeting Abstract

    Aguirre, N.; Veach, D.; Guo, H. F.; Espinosa-Cotton, M.; Fung, E.; Xu, H.; Feng, Y.; Leung, K.; Cheung, I.; Carrasco, S.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Anti-GPA33 pretargeted radioimmunotherapy (PRIT) of colorectal cancer (CRC) using a self-assembling and dis-assembling (SADA) bispecific antibody to deliver 177Lu-bivalent benzyl-DOTA
    Meeting Abstract

    Le Roux, A.; Fung, E.; Xu, H.; Vargas, D. B.; Rinne, S. S.; Guo, H. F.; Leung, K.; Feng, Y.; Cheung, I.; Ouerfelli, O.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Long prime-boost interval and heightened anti-GD2 antibody response to carbohydrate cancer vaccine
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Basu, E. M.; Feng, Y.; Kushner, B. H.; Cheung, N. K.
    Vaccines (2024)

    Fulltext@MSK | Save
  • Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects
    Journal Article

    Mora, J.; Climent, A.; Roldán, M.; Flores, M. C.; Varo, A.; Perez-Jaume, S.; Jou, C.; Celma, M. S.; Lazaro, J. J.; Cheung, I.; more...
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Gut microbiota associations with GD2/GD3 vaccine response in patients with high-risk neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Nguyen, C.; Cheung, I.; Kushner, B.; Mauguen, A.; Waters, N.; Dai, A.; Kivovich, V.; Littmann, E.; Harford, L.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Clonal evolution during metastatic spread in high-risk neuroblastoma
    Journal Article

    Gundem, G.; Levine, M. F.; Roberts, S. S.; Cheung, I. Y.; Medina-Martínez, J. S.; Feng, Y.; Arango-Ossa, J. E.; Chadoutaud, L.; Rita, M.; Asimomitis, G.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial
    Meeting Abstract

    Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Novel infusion strategy to reduce major side effects caused by anti-GD2 monoclonal antibody naxitamab without affecting its pharmacokinetics
    Meeting Abstract

    Mora, J.; Varo, A.; Castañeda, A.; Chamorro, S.; Muñoz, J. P.; Gorostegui, M.; Celma, M. S.; Lopez, S.; Simao, M.; Perez-Jaume, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save